Effectiveness of a Manual Therapy Protocol on Women With Pelvic Pain Due to Endometriosis

Sponsor
University of Valencia (Other)
Overall Status
Recruiting
CT.gov ID
NCT05418751
Collaborator
(none)
40
1
2
25.9
1.5

Study Details

Study Description

Brief Summary

Endometriosis is a debilitating disease with features of chronic inflammation that affects 10-15% of women of reproductive age. Pelvic pain is one of the most common symptoms in women with endometriosis, and many of them report that it affects their quality of life. In addition, women with endometriosis, especially those with pelvic pain, also have an increased vulnerability to various psychiatric disorders, such as depression and anxiety.

In this context, physical therapy can contribute to the multidisciplinary assessment and treatment of pelvic pain. In addition, manual therapy could improve certain variables related to central sensitization, such as inhibitory pain regulation and neuronal excitability in the dorsal horn of the medulla, in patients with chronic pain. Some prospective studies have applied manual therapy in patients with pelvic pain due to endometriosis, and have shown a trend towards improvement of pain and quality of life. Moreover, it is considered a well-tolerated and accepted treatment by patients.

However, to date, it has not been investigated whether the application of a manual therapy protocol improves pelvic pain and other endometriosis-associated symptoms, lumbar mobility, medication intake, depression and anxiety levels, and quality of life in women with endometriosis-associated pelvic pain compared to a placebo treatment.

Condition or Disease Intervention/Treatment Phase
  • Other: Manual therapy
  • Other: Placebo treatment
N/A

Detailed Description

Endometriosis is a debilitating disease with features of chronic inflammation that affects 10-15% of women of reproductive age. Pelvic pain is one of the most common symptoms in women with endometriosis, and many of them report that it affects their quality of life. In addition, women with endometriosis, especially those with pelvic pain, also have an increased vulnerability to various psychiatric disorders, such as depression and anxiety.

In this context, physical therapy can contribute to the multidisciplinary assessment and treatment of pelvic pain. In addition, manual therapy could improve certain variables related to central sensitization, such as inhibitory pain regulation and neuronal excitability in the dorsal horn of the medulla, in patients with chronic pain. Some prospective studies have applied manual therapy in patients with pelvic pain due to endometriosis, and have shown a trend towards improvement of pain and quality of life. Moreover, it is considered a well-tolerated and accepted treatment by patients.

However, to date, it has not been investigated whether the application of a manual therapy protocol improves pelvic pain and other endometriosis-associated symptoms, lumbar mobility, medication intake, depression and anxiety levels, and quality of life in women with endometriosis-associated pelvic pain compared to a placebo treatment.

Therefore, this is a randomized clinical trial in which two groups of twenty people in each group will participate, with different interventions:

  • Experimental group: manual therapy protocol.

  • Placebo group: placebo treatment. Participants will be evaluated in four moments, at baseline, post-intervention, 1-month follow-up and 6-month follow-up.

Data analysis will be performed with SPSS statistic program (v24). Normality and homoscedasticity will be analyzed by Shapiro-Wilk t-test and Levene test, respectively. Multifactorial ANOVA will be performed with two groups (experimental and placebo group) and four-time assessments. For comparation between groups Bonferroni will be used. When p<0.05 statistically significant differences will be assumed.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effectiveness of a Manual Therapy Protocol on Women With Pelvic Pain Due to Endometriosis: a Randomised Clinical Trial
Actual Study Start Date :
Nov 1, 2021
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Dec 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Manual therapy group

Patients in this group (n=20) will receive a manual therapy protocol.

Other: Manual therapy
Participants will received a manual therapy protocol consisting of the following techniques: manipulation of the occipito-atlanto-axial joint (C0-C1-C2), suboccipital inhibition technique, manipulation of the thoracolumbar hinge (T12-L1), global manipulation of the bilateral pelvis, global abdominal hemodynamic technique, functional technique of the pelvic diaphragm and stretching of the lumbopelvic musculature.

Placebo Comparator: Placebo group

Patients in this group (n=20) will receive a placebo treatment.

Other: Placebo treatment
Participants will receive light contact on the same points and for the same amount of time as the experimental group, with no intention to treat.

Outcome Measures

Primary Outcome Measures

  1. Pelvic pain. Mohedo Questionnaire [5 minutes]

    From 0 to 27 points. Higher scores mean a worse outcome.

  2. Endometriosis symptoms. The endometriosis health profile questionnaire (EHP-30Q) [5 minutes]

    5-point Likert scale, where 0=never, 1=rarely, 2=sometimes, 3=often, and 4=always. Raw scores for the questions within a scale are summed and transformed to a 0-100 scale, with higher scores indicating worse health-related quality of life.

Secondary Outcome Measures

  1. Health related quality of life. 36-Item Short Form Survey (SF-36) [5 minutes]

    From 0 to 100 points. Higher scores mean a better outcome.

  2. Lumbar range of movement. Modified Schober Test [5 minutes]

    Higher scores mean a better outcome.< 2cm indicates severe restriction in lumbar flexion, 2-4 cm indicates moderate restriction and >4 cm indicates without restriction.

  3. Depression. Beck Depression Index (BDI-II) [5 minutes]

    From 0 to 21 points. Higher scores mean greater depression.

  4. Anxiety. State Trait Anxiety Index (STAI) [5 minutes]

    Scores range from 20 to 80, with higher scores correlating with greater anxiety.

  5. Medication intake. Diary [8 months]

    Name of the drug, dosage and frequency of intake.

  6. Impression of change after treatment. Patient global Perception of Change Scale (PGICS) [1 minute]

    From 1 to 7. Scale where 7=very much improved, 6= much improved, 5=minimally improved, 4=no change, 3=minimally worse, 2=much worse, 1=very much worse."

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pre-menopausal woman aged between 18 and 50 years.

  • Diagnosis of endometriosis and associated pelvic pain.

Exclusion Criteria:
  • Being pregnant.

  • Having rheumatic or degenerative neurological diseases, as well as any other injury or disease that causes pelvic pain.

  • Any pelvic surgery of less than one year of evolution (for example, cesarean sections).

  • Having received physical therapy treatment within the last three months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Physiotherapy, University of Valencia Valencia Spain 46022

Sponsors and Collaborators

  • University of Valencia

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Marta Inglés de la Torre, Professor, University of Valencia
ClinicalTrials.gov Identifier:
NCT05418751
Other Study ID Numbers:
  • 19866206
First Posted:
Jun 14, 2022
Last Update Posted:
Jun 22, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2022